Surety medicine focuses on protecting the health of the personnel who deal with nuclear, biological or chemical materials, and on medical requirements compliance to help ensure the security of the materials.

February 2019 Surety Medicine Teleconference:

CARDIOVASCULAR SCREENING OF SECURITY GUARDS
AND POLICE: PRP AND IRP CONSIDERATIONS

Wednesday, 20 February 2019 will bring the next Surety Medicine Teleconference, at 1 pm (1300 hrs) Eastern Time. The topic for January is "Cardiovascular Screening of Security Guards and Police: Personnel Reliability Program and Individual Reliability Program Considerations.” The presenter will be a physician from the Army Public Health Center Occupational Medicine Division.

To request additional information, email the Army Public Health Center Surety Medicine Division at:
usarmy.apg.medcom-aphc.mbx.surety-medicine@mail.mil.

SCHEDULE OF UPCOMING SURETY MEDICINE TELECONFERENCES

(subject to change)

16 JAN 2019	Ionizing Radiation Dosimetry and the Nuclear PRP: Interfaces between the Health Physicist and CMA
20 FEB 2019	Cardiovascular Screening of Security Guards and Police: PRP and IRP Considerations
20 MAR 2019	The Dental Officer’s Perspective on Supporting the Personnel Reliability Program
17 APR 2019	Bloodborne Pathogen Exposures: Pre- and Post-Expsoure Prophylaxis
15 MAY 2019	Substance Use Disorder Clinical Care (SUDCC) Intake Evaluations for PRP Candidates: Suggested Approach
19 JUN 2019	Changing Most Probable Event Requirements in the Chemical Storage and Demilitarization Environment
17 JUL 2019	Diagnosis, Evaluation and Treatment of Laboratory-Acquired Botulinum Toxin Exposures
21 AUG 2019	Certifying Official, Behavioral Health Specialist, and CMA Interactions: PRP Case Studies
18 SEP 2019	Urinary Metabolites, Protein Adducts and Bio-markers of Nerve and Vesicant Exposures

--ALERT--

Auto-Injector Shelf Life Extension Program:

NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM

Three production lots of atropine nerve agent antidote auto-injectors expired 31 January 2018, and additional lots expired in September 2018! Check any auto-injector medication stores you have. Select the link below for additional information.

The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote(R) combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labeled expiration dates, some are now extended to 2022. Complete FDA information related to the auto-injector shelf life extension program can be found at this FDA Drug Safety Page .

Information on this page also includes the latest updates (03/23/2018) on shelf life extensions for the AtroPen(R) (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors.

Surety Medicine